Clinico - Laboratory Profile of Scrub Typhus - An Emerging Rickettsiosis in India

Dinesh Kumar Narayanasamy1, Arul Kumaran Arunagirinathan2, Revathi Krishna Kumar2

  • 1Department of Pediatrics, Sri Manakula Vinayagar Medical College & Hospital, Pondicherry, 605107, Tamil Nadu, India. dinesh.paed@gmail.com.

Insights

Pediatric scrub typhus in rural India presents with fever, gastrointestinal issues, and common symptoms like cough and vomiting. Early empirical treatment with Doxycycline or Azithromycin is crucial for preventing severe complications.

Area of Science:

  • Infectious Diseases
  • Pediatrics
  • Tropical Medicine

Background:

  • Scrub typhus, a zoonotic disease caused by Orientia tsutsugamushi, poses a significant health burden in endemic areas.
  • Early diagnosis and treatment are critical to prevent severe morbidity and mortality, particularly in pediatric populations.

Purpose of the Study:

  • To elucidate the clinical manifestations and laboratory findings of scrub typhus in children residing in rural South India.
  • To identify key indicators for early diagnosis and management of pediatric scrub typhus.

Main Methods:

  • A descriptive study was conducted on 117 children diagnosed with scrub typhus (IgM ELISA positive) out of 448 admitted pediatric patients.
  • Data collection occurred between November 2014 and March 2015 at a tertiary care hospital.

Main Results:

  • Fever (100%), gastrointestinal symptoms (51%), cough (82%), myalgia (70%), and vomiting (68%) were prevalent. Common clinical findings included hepatomegaly (70%), splenomegaly (53%), pallor (50%), and eschar (41%).
  • Key laboratory findings were leucocytosis (50%), anemia (56%), elevated SGOT/SGPT (47%), and thrombocytopenia (41%). Complications included shock (46%), myocarditis (24%), and pneumonia (16%).
  • Early treatment correlated with good outcomes, including rapid recovery and zero mortality.

Conclusions:

  • Regional lymphadenopathy can indicate a developing eschar, and laboratory results should be interpreted considering fever duration.
  • In resource-limited settings where IgM ELISA may not be readily available, empirical treatment with Doxycycline or Azithromycin is recommended for febrile children with suggestive clinical and laboratory findings to prevent severe complications.
Abstract